Wellell Inc Asset Resilience Ratio
Wellell Inc asset resilience ratio. Wellell Inc (4106) has an Asset Resilience Ratio of 2.43% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 4106 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Wellell Inc (2002–2024)
Asset resilience ratio of Wellell Inc from 2002 to 2024. This chart shows how Wellell Inc's Asset Resilience Ratio has changed over time. Read total liabilities of Wellell Inc for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Wellell Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Wellell Inc assets under control.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$77.17 Million | 2.43% |
| Total Liquid Assets | NT$77.17 Million | 2.43% |
Asset Resilience Insights
- Limited Liquidity: Wellell Inc maintains only 2.43% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Wellell Inc Industry Peers by Asset Resilience Ratio
Compare Wellell Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Applied BioCode
TW:6598 |
Medical Devices | 9.75% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Radiant Innovation
TWO:3373 |
Medical Devices | 0.82% |
|
Impedimed Ltd
AU:IPD |
Medical Devices | 46.15% |
|
Memphasys Ltd
AU:MEM |
Medical Devices | 0.00% |
Wellell Inc Asset Resilience Ratio by Year (2002–2024)
Wellell Inc asset resilience ratio by year from 2002 to 2024. The table below shows the annual Asset Resilience Ratio data for Wellell Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 4.19% | NT$131.33 Million ≈ $4.14 Million |
NT$3.14 Billion ≈ $98.86 Million |
+0.75pp |
| 2023-12-31 | 3.44% | NT$110.93 Million ≈ $3.49 Million |
NT$3.22 Billion ≈ $101.60 Million |
+0.15pp |
| 2022-12-31 | 3.29% | NT$105.16 Million ≈ $3.31 Million |
NT$3.20 Billion ≈ $100.74 Million |
-0.07pp |
| 2021-12-31 | 3.36% | NT$105.59 Million ≈ $3.33 Million |
NT$3.14 Billion ≈ $98.94 Million |
-1.67pp |
| 2020-12-31 | 5.03% | NT$153.30 Million ≈ $4.83 Million |
NT$3.05 Billion ≈ $95.98 Million |
-7.01pp |
| 2019-12-31 | 12.04% | NT$363.61 Million ≈ $11.46 Million |
NT$3.02 Billion ≈ $95.16 Million |
-4.01pp |
| 2018-12-31 | 16.05% | NT$504.99 Million ≈ $15.91 Million |
NT$3.15 Billion ≈ $99.12 Million |
+9.88pp |
| 2017-12-31 | 6.17% | NT$159.49 Million ≈ $5.02 Million |
NT$2.58 Billion ≈ $81.42 Million |
-0.80pp |
| 2016-12-31 | 6.97% | NT$180.59 Million ≈ $5.69 Million |
NT$2.59 Billion ≈ $81.63 Million |
-0.65pp |
| 2015-12-31 | 7.62% | NT$190.51 Million ≈ $6.00 Million |
NT$2.50 Billion ≈ $78.79 Million |
-2.68pp |
| 2014-12-31 | 10.30% | NT$259.44 Million ≈ $8.17 Million |
NT$2.52 Billion ≈ $79.35 Million |
+1.26pp |
| 2013-12-31 | 9.04% | NT$219.61 Million ≈ $6.92 Million |
NT$2.43 Billion ≈ $76.54 Million |
+1.69pp |
| 2012-12-31 | 7.35% | NT$158.44 Million ≈ $4.99 Million |
NT$2.15 Billion ≈ $67.89 Million |
+7.34pp |
| 2011-12-31 | 0.01% | NT$221.00K ≈ $6.96K |
NT$1.95 Billion ≈ $61.37 Million |
-4.37pp |
| 2010-12-31 | 4.39% | NT$71.09 Million ≈ $2.24 Million |
NT$1.62 Billion ≈ $51.07 Million |
+0.75pp |
| 2009-12-31 | 3.64% | NT$60.02 Million ≈ $1.89 Million |
NT$1.65 Billion ≈ $51.98 Million |
-1.78pp |
| 2008-12-31 | 5.42% | NT$95.43 Million ≈ $3.01 Million |
NT$1.76 Billion ≈ $55.48 Million |
+0.00pp |
| 2007-12-31 | 5.41% | NT$87.38 Million ≈ $2.75 Million |
NT$1.61 Billion ≈ $50.84 Million |
-1.95pp |
| 2005-12-31 | 7.36% | NT$100.43 Million ≈ $3.16 Million |
NT$1.36 Billion ≈ $42.99 Million |
-4.50pp |
| 2004-12-31 | 11.86% | NT$144.07 Million ≈ $4.54 Million |
NT$1.22 Billion ≈ $38.28 Million |
-0.50pp |
| 2003-12-31 | 12.36% | NT$148.08 Million ≈ $4.67 Million |
NT$1.20 Billion ≈ $37.76 Million |
-0.89pp |
| 2002-12-31 | 13.24% | NT$80.00 Million ≈ $2.52 Million |
NT$604.01 Million ≈ $19.03 Million |
-- |
About Wellell Inc
Wellell Inc. engages in the manufacture and sale of medical supplies in Europe, the United States, Asia, and internationally. The company offers support surface systems, respiratory therapy devices, and other products. It also provides pressure relief mattress; sleep apnea such as auto-adjusting pressure; sleepwell; compression therapy; and pressure relief seating products. In addition, the compa… Read more